Structure

Physi-Chem Properties

Molecular Weight:  210.05
Volume:  203.729
LogP:  2.014
LogD:  0.936
LogS:  -2.663
# Rotatable Bonds:  2
TPSA:  94.83
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  1
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.637
Synthetic Accessibility Score:  2.458
Fsp3:  0.2
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.966
MDCK Permeability:  9.51685979089234e-06
Pgp-inhibitor:  0.009
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.031
20% Bioavailability (F20%):  0.409
30% Bioavailability (F30%):  0.496

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.015
Plasma Protein Binding (PPB):  93.70198059082031%
Volume Distribution (VD):  0.872
Pgp-substrate:  6.391941547393799%

ADMET: Metabolism

CYP1A2-inhibitor:  0.921
CYP1A2-substrate:  0.31
CYP2C19-inhibitor:  0.122
CYP2C19-substrate:  0.057
CYP2C9-inhibitor:  0.466
CYP2C9-substrate:  0.605
CYP2D6-inhibitor:  0.514
CYP2D6-substrate:  0.204
CYP3A4-inhibitor:  0.594
CYP3A4-substrate:  0.156

ADMET: Excretion

Clearance (CL):  4.43
Half-life (T1/2):  0.767

ADMET: Toxicity

hERG Blockers:  0.027
Human Hepatotoxicity (H-HT):  0.065
Drug-inuced Liver Injury (DILI):  0.926
AMES Toxicity:  0.457
Rat Oral Acute Toxicity:  0.038
Maximum Recommended Daily Dose:  0.061
Skin Sensitization:  0.753
Carcinogencity:  0.059
Eye Corrosion:  0.038
Eye Irritation:  0.929
Respiratory Toxicity:  0.763

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC226275

Natural Product ID:  NPC226275
Common Name*:   1-(3-Acetyl-2,4,6-Trihydroxyphenyl)Ethanone
IUPAC Name:   1-(3-acetyl-2,4,6-trihydroxyphenyl)ethanone
Synonyms:   2,4-Diacetyl Phloroglucinol
Standard InCHIKey:  PIFFQYJYNWXNGE-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C10H10O5/c1-4(11)8-6(13)3-7(14)9(5(2)12)10(8)15/h3,13-15H,1-2H3
SMILES:  CC(=O)c1c(cc(c(C(=O)C)c1O)O)O
Synthetic Gene Cluster:   BGC0000280;BGC0000281;
ChEMBL Identifier:   CHEMBL276139
PubChem CID:   16547
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0001831] Carbonyl compounds
          • [CHEMONTID:0000118] Ketones
            • [CHEMONTID:0003670] Aryl ketones
              • [CHEMONTID:0004296] Phenylketones
                • [CHEMONTID:0004298] Alkyl-phenylketones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8513 Pseudomonas fluorescens Species Pseudomonadaceae Bacteria n.a. n.a. n.a. PMID[15826166]
NPO8513 Pseudomonas fluorescens Species Pseudomonadaceae Bacteria n.a. n.a. n.a. PMID[17924666]
NPO29941 Lysobacter gummosus Species Xanthomonadaceae Bacteria n.a. n.a. n.a. PMID[18058176]
NPO8513 Pseudomonas fluorescens Species Pseudomonadaceae Bacteria n.a. n.a. n.a. PMID[20979386]
NPO8513 Pseudomonas fluorescens Species Pseudomonadaceae Bacteria n.a. n.a. n.a. PMID[23688329]
NPO8513 Pseudomonas fluorescens Species Pseudomonadaceae Bacteria n.a. n.a. n.a. PMID[23897464]
NPO31175 Pseudomonas protegens Species Pseudomonadaceae Bacteria n.a. n.a. n.a. PMID[24742073]
NPO12957 Piper auritum Species Piperaceae Eukaryota n.a. n.a. n.a. PMID[28704049]
NPO8513 Pseudomonas fluorescens Species Pseudomonadaceae Bacteria n.a. n.a. n.a. PMID[7798954]
NPO8513 Pseudomonas fluorescens Species Pseudomonadaceae Bacteria n.a. n.a. n.a. PMID[8626242]
NPO12957 Piper auritum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO8513 Pseudomonas fluorescens Species Pseudomonadaceae Bacteria n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT80 Cell Line Raji Homo sapiens Viability = 60.0 % PMID[572558]
NPT189 Cell Line Vero Chlorocebus aethiops IC50 = 12.0 ug.mL-1 PMID[572559]
NPT857 Cell Line LLC-PK1 Sus scrofa IC50 = 11.0 ug.mL-1 PMID[572559]
NPT531 Individual Protein Nuclear receptor ROR-gamma Mus musculus Potency = 10000.0 nM PMID[572560]
NPT54 Individual Protein Nonstructural protein 1 Influenza A virus Potency = 10000.0 nM PMID[572560]
NPT531 Individual Protein Nuclear receptor ROR-gamma Mus musculus Potency = 2818.4 nM PMID[572560]
NPT1254 Individual Protein Streptokinase A Streptococcus pyogenes serotype M1 EC50 = 2635.0 nM PMID[572560]
NPT152 Individual Protein Nuclear factor erythroid 2-related factor 2 Homo sapiens Potency n.a. 25929.0 nM PMID[572560]
NPT64 Individual Protein ATPase family AAA domain-containing protein 5 Homo sapiens Potency n.a. 12990.0 nM PMID[572560]
NPT65 Cell Line HepG2 Homo sapiens Potency n.a. 3981.1 nM PMID[572560]
NPT154 Individual Protein Mothers against decapentaplegic homolog 3 Homo sapiens Potency n.a. 22387.2 nM PMID[572560]
NPT369 Cell Line ACHN Homo sapiens GI = 44.0 % PMID[572561]
NPT461 Cell Line PANC-1 Homo sapiens GI = 0.0 % PMID[572561]
NPT1307 Cell Line Calu-1 Homo sapiens GI = 0.0 % PMID[572561]
NPT397 Cell Line NCI-H460 Homo sapiens GI = 25.0 % PMID[572561]
NPT393 Cell Line HCT-116 Homo sapiens GI = 0.0 % PMID[572561]
NPT210 Individual Protein Thyroid stimulating hormone receptor Homo sapiens Potency n.a. 30131.3 nM PMID[572560]
NPT1797 Individual Protein Alpha trans-inducing protein (VP16) Herpes simplex virus (type 1 / strain 17) IC50 n.a. 4561.0 nM PMID[572560]
NPT1798 Individual Protein Photoreceptor-specific nuclear receptor Homo sapiens IC50 n.a. 3238.0 nM PMID[572560]
NPT10 Individual Protein Geminin Homo sapiens Potency n.a. 1458.1 nM PMID[572560]
NPT478 Individual Protein Ataxin-2 Homo sapiens Potency n.a. 7079.5 nM PMID[572560]
NPT101 Individual Protein Glucagon-like peptide 1 receptor Homo sapiens Potency n.a. 7943.3 nM PMID[572560]
NPT50 Individual Protein Tyrosyl-DNA phosphodiesterase 1 Homo sapiens Potency n.a. 25929.0 nM PMID[572560]
NPT50 Individual Protein Tyrosyl-DNA phosphodiesterase 1 Homo sapiens Potency n.a. 20596.2 nM PMID[572560]
NPT160 Individual Protein TAR DNA-binding protein 43 Homo sapiens Potency n.a. 35481.3 nM PMID[572560]
NPT535 Individual Protein Parathyroid hormone receptor Homo sapiens Potency n.a. 50118.7 nM PMID[572560]
NPT11 Individual Protein Guanine nucleotide-binding protein G(s), subunit alpha Homo sapiens Potency n.a. 35481.3 nM PMID[572560]
NPT589 Individual Protein Serum albumin Bos taurus Inhibition = 83.0 % PMID[572562]
NPT589 Individual Protein Serum albumin Bos taurus EC50 = 6300000.0 nM PMID[572562]
NPT938 Organism Cavia porcellus Cavia porcellus Inhibition = 44.3 % PMID[572557]
NPT938 Organism Cavia porcellus Cavia porcellus Inhibition = 39.1 % PMID[572557]
NPT633 Organism Leishmania donovani Leishmania donovani IC50 = 27.0 ug.mL-1 PMID[572559]
NPT633 Organism Leishmania donovani Leishmania donovani IC90 > 40.0 ug.mL-1 PMID[572559]
NPT174 Organism Streptococcus Streptococcus EC50 = 3976.0 nM PMID[572560]
NPT1252 Organism Streptococcus sp. 'group A' Streptococcus sp. 'group A' EC50 = 3897.0 nM PMID[572560]
NPT312 Organism Saccharomyces cerevisiae Saccharomyces cerevisiae Potency = 11220.2 nM PMID[572560]
NPT536 Uncleic Acid microRNA 21 Homo sapiens Potency = 26121.6 nM PMID[572560]
NPT2 Others Unspecified Potency = 16360.1 nM PMID[572560]
NPT2 Others Unspecified Potency n.a. 35481.3 nM PMID[572560]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Potency n.a. 10417.9 nM PMID[572560]
NPT2 Others Unspecified Potency n.a. 10000.0 nM PMID[572560]
NPT2 Others Unspecified Potency n.a. 3548.1 nM PMID[572560]
NPT755 Individual Protein Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 Homo sapiens Potency n.a. 25118.9 nM PMID[572560]
NPT2 Others Unspecified Potency n.a. 18356.4 nM PMID[572560]
NPT861 Individual Protein Isocitrate dehydrogenase [NADP] cytoplasmic Homo sapiens Potency n.a. 12995.3 nM PMID[572560]
NPT920 Individual Protein Alpha-synuclein Homo sapiens Potency n.a. 15848.9 nM PMID[572560]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC226275 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9655 High Similarity NPC215392
0.9573 High Similarity NPC91105
0.9492 High Similarity NPC65761
0.9492 High Similarity NPC472029
0.9483 High Similarity NPC294037
0.9478 High Similarity NPC209486
0.9478 High Similarity NPC40649
0.9407 High Similarity NPC309765
0.9402 High Similarity NPC146642
0.9402 High Similarity NPC149246
0.9333 High Similarity NPC475733
0.9322 High Similarity NPC303737
0.9256 High Similarity NPC267846
0.9231 High Similarity NPC161617
0.918 High Similarity NPC23126
0.918 High Similarity NPC98254
0.918 High Similarity NPC169250
0.918 High Similarity NPC100067
0.918 High Similarity NPC30501
0.918 High Similarity NPC103356
0.918 High Similarity NPC72158
0.918 High Similarity NPC116513
0.918 High Similarity NPC105157
0.918 High Similarity NPC162612
0.918 High Similarity NPC190043
0.918 High Similarity NPC266689
0.916 High Similarity NPC242895
0.9106 High Similarity NPC221777
0.9106 High Similarity NPC473017
0.9106 High Similarity NPC21305
0.9098 High Similarity NPC62952
0.9083 High Similarity NPC133909
0.9083 High Similarity NPC218333
0.9083 High Similarity NPC232708
0.9083 High Similarity NPC32032
0.9048 High Similarity NPC48036
0.904 High Similarity NPC275504
0.9032 High Similarity NPC474998
0.9032 High Similarity NPC230818
0.9008 High Similarity NPC306288
0.9 High Similarity NPC143427
0.9 High Similarity NPC73532
0.9 High Similarity NPC224273
0.9 High Similarity NPC156139
0.9 High Similarity NPC19174
0.9 High Similarity NPC115159
0.9 High Similarity NPC267552
0.9 High Similarity NPC45438
0.8976 High Similarity NPC474519
0.8966 High Similarity NPC118288
0.8966 High Similarity NPC276111
0.896 High Similarity NPC84772
0.8952 High Similarity NPC41263
0.8917 High Similarity NPC229649
0.8917 High Similarity NPC297186
0.8898 High Similarity NPC121259
0.8889 High Similarity NPC324482
0.8889 High Similarity NPC475042
0.888 High Similarity NPC476119
0.8862 High Similarity NPC10926
0.8862 High Similarity NPC477454
0.8843 High Similarity NPC196976
0.8833 High Similarity NPC159525
0.8819 High Similarity NPC27490
0.879 High Similarity NPC473751
0.879 High Similarity NPC328983
0.879 High Similarity NPC8745
0.879 High Similarity NPC473691
0.878 High Similarity NPC13238
0.877 High Similarity NPC66252
0.8769 High Similarity NPC222633
0.875 High Similarity NPC139074
0.875 High Similarity NPC267205
0.875 High Similarity NPC40524
0.875 High Similarity NPC213485
0.875 High Similarity NPC158222
0.8739 High Similarity NPC230349
0.873 High Similarity NPC69235
0.873 High Similarity NPC212379
0.872 High Similarity NPC305518
0.872 High Similarity NPC128428
0.872 High Similarity NPC329205
0.872 High Similarity NPC316625
0.871 High Similarity NPC262671
0.871 High Similarity NPC201728
0.8682 High Similarity NPC166480
0.8682 High Similarity NPC93756
0.8682 High Similarity NPC282780
0.8682 High Similarity NPC108113
0.8672 High Similarity NPC175738
0.8667 High Similarity NPC241089
0.8661 High Similarity NPC62219
0.8651 High Similarity NPC470981
0.8636 High Similarity NPC162939
0.8615 High Similarity NPC278375
0.8615 High Similarity NPC283590
0.8615 High Similarity NPC61153
0.8615 High Similarity NPC125920
0.8615 High Similarity NPC470210
0.8615 High Similarity NPC164136
0.8615 High Similarity NPC130899
0.8615 High Similarity NPC70859
0.8605 High Similarity NPC285054
0.8605 High Similarity NPC37299
0.8605 High Similarity NPC180261
0.8605 High Similarity NPC103105
0.8595 High Similarity NPC188814
0.8595 High Similarity NPC195262
0.8583 High Similarity NPC102829
0.8583 High Similarity NPC120488
0.8583 High Similarity NPC92624
0.856 High Similarity NPC290466
0.8559 High Similarity NPC242136
0.855 High Similarity NPC13575
0.855 High Similarity NPC191976
0.855 High Similarity NPC65005
0.855 High Similarity NPC194764
0.855 High Similarity NPC84699
0.855 High Similarity NPC60667
0.855 High Similarity NPC264112
0.855 High Similarity NPC131039
0.855 High Similarity NPC254847
0.8538 High Similarity NPC475088
0.8516 High Similarity NPC259942
0.8516 High Similarity NPC247477
0.8516 High Similarity NPC17840
0.8516 High Similarity NPC21378
0.8516 High Similarity NPC470987
0.8516 High Similarity NPC233056
0.8512 High Similarity NPC283844
0.8507 High Similarity NPC16455
0.8507 High Similarity NPC307990
0.8504 High Similarity NPC186098
0.8504 High Similarity NPC80694
0.8492 Intermediate Similarity NPC95309
0.8485 Intermediate Similarity NPC98115
0.8485 Intermediate Similarity NPC65837
0.8485 Intermediate Similarity NPC471905
0.8485 Intermediate Similarity NPC156910
0.8485 Intermediate Similarity NPC477242
0.8485 Intermediate Similarity NPC186838
0.8485 Intermediate Similarity NPC178467
0.8485 Intermediate Similarity NPC150399
0.8485 Intermediate Similarity NPC477243
0.8485 Intermediate Similarity NPC274109
0.8485 Intermediate Similarity NPC149372
0.8485 Intermediate Similarity NPC477244
0.8485 Intermediate Similarity NPC474771
0.8485 Intermediate Similarity NPC53206
0.8485 Intermediate Similarity NPC174999
0.8485 Intermediate Similarity NPC53414
0.8485 Intermediate Similarity NPC474849
0.8485 Intermediate Similarity NPC249606
0.8485 Intermediate Similarity NPC41461
0.8485 Intermediate Similarity NPC1486
0.8485 Intermediate Similarity NPC25287
0.8485 Intermediate Similarity NPC12165
0.8485 Intermediate Similarity NPC66349
0.8485 Intermediate Similarity NPC168105
0.8473 Intermediate Similarity NPC103842
0.8473 Intermediate Similarity NPC290803
0.8455 Intermediate Similarity NPC248363
0.845 Intermediate Similarity NPC198249
0.845 Intermediate Similarity NPC250057
0.845 Intermediate Similarity NPC270369
0.845 Intermediate Similarity NPC5515
0.8444 Intermediate Similarity NPC193555
0.8438 Intermediate Similarity NPC109123
0.8421 Intermediate Similarity NPC317119
0.8421 Intermediate Similarity NPC153979
0.8421 Intermediate Similarity NPC475974
0.8421 Intermediate Similarity NPC472419
0.8409 Intermediate Similarity NPC158481
0.8409 Intermediate Similarity NPC151113
0.8409 Intermediate Similarity NPC156092
0.8409 Intermediate Similarity NPC50455
0.8409 Intermediate Similarity NPC118919
0.8403 Intermediate Similarity NPC223004
0.8397 Intermediate Similarity NPC18877
0.8397 Intermediate Similarity NPC82225
0.8397 Intermediate Similarity NPC28753
0.8397 Intermediate Similarity NPC159623
0.8397 Intermediate Similarity NPC204960
0.8397 Intermediate Similarity NPC294593
0.8397 Intermediate Similarity NPC20560
0.8397 Intermediate Similarity NPC144051
0.8397 Intermediate Similarity NPC44437
0.8385 Intermediate Similarity NPC31872
0.8385 Intermediate Similarity NPC262359
0.8385 Intermediate Similarity NPC475589
0.8385 Intermediate Similarity NPC473584
0.8385 Intermediate Similarity NPC135801
0.8385 Intermediate Similarity NPC185624
0.8385 Intermediate Similarity NPC313618
0.8372 Intermediate Similarity NPC26697
0.8372 Intermediate Similarity NPC147757
0.837 Intermediate Similarity NPC28337
0.837 Intermediate Similarity NPC290550
0.8361 Intermediate Similarity NPC273282
0.8361 Intermediate Similarity NPC474890

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC226275 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.855 High Similarity NPD1509 Clinical (unspecified phase)
0.8385 Intermediate Similarity NPD1240 Approved
0.8385 Intermediate Similarity NPD943 Approved
0.8258 Intermediate Similarity NPD1607 Approved
0.8134 Intermediate Similarity NPD1510 Phase 2
0.8058 Intermediate Similarity NPD7390 Discontinued
0.8015 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8015 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7985 Intermediate Similarity NPD6651 Approved
0.7956 Intermediate Similarity NPD1549 Phase 2
0.7899 Intermediate Similarity NPD2800 Approved
0.7872 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7846 Intermediate Similarity NPD1164 Approved
0.7833 Intermediate Similarity NPD74 Approved
0.7833 Intermediate Similarity NPD9266 Approved
0.7826 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD1201 Approved
0.7793 Intermediate Similarity NPD7411 Suspended
0.7778 Intermediate Similarity NPD940 Approved
0.7778 Intermediate Similarity NPD846 Approved
0.776 Intermediate Similarity NPD9493 Approved
0.7755 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD9264 Approved
0.775 Intermediate Similarity NPD9263 Approved
0.775 Intermediate Similarity NPD9267 Approved
0.771 Intermediate Similarity NPD1470 Approved
0.7615 Intermediate Similarity NPD9269 Phase 2
0.7603 Intermediate Similarity NPD4380 Phase 2
0.7578 Intermediate Similarity NPD9268 Approved
0.7568 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7552 Intermediate Similarity NPD1511 Approved
0.7518 Intermediate Similarity NPD1243 Approved
0.75 Intermediate Similarity NPD2532 Approved
0.75 Intermediate Similarity NPD2534 Approved
0.75 Intermediate Similarity NPD2533 Approved
0.75 Intermediate Similarity NPD9545 Approved
0.748 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.746 Intermediate Similarity NPD9281 Approved
0.7448 Intermediate Similarity NPD1512 Approved
0.7429 Intermediate Similarity NPD5406 Approved
0.7429 Intermediate Similarity NPD5408 Approved
0.7429 Intermediate Similarity NPD5404 Approved
0.7429 Intermediate Similarity NPD2935 Discontinued
0.7429 Intermediate Similarity NPD2796 Approved
0.7429 Intermediate Similarity NPD5405 Approved
0.7417 Intermediate Similarity NPD7075 Discontinued
0.7417 Intermediate Similarity NPD9261 Approved
0.7394 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD230 Phase 1
0.7383 Intermediate Similarity NPD6801 Discontinued
0.7383 Intermediate Similarity NPD1934 Approved
0.7355 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7348 Intermediate Similarity NPD9717 Approved
0.7343 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7819 Suspended
0.731 Intermediate Similarity NPD6799 Approved
0.7279 Intermediate Similarity NPD920 Approved
0.7273 Intermediate Similarity NPD6959 Discontinued
0.7273 Intermediate Similarity NPD2654 Approved
0.7222 Intermediate Similarity NPD3750 Approved
0.7219 Intermediate Similarity NPD2801 Approved
0.7185 Intermediate Similarity NPD1203 Approved
0.7183 Intermediate Similarity NPD1551 Phase 2
0.7133 Intermediate Similarity NPD6599 Discontinued
0.7133 Intermediate Similarity NPD2344 Approved
0.7124 Intermediate Similarity NPD3882 Suspended
0.7124 Intermediate Similarity NPD7768 Phase 2
0.7123 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD6232 Discontinued
0.7113 Intermediate Similarity NPD2799 Discontinued
0.7089 Intermediate Similarity NPD7473 Discontinued
0.7078 Intermediate Similarity NPD3749 Approved
0.7078 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD4750 Phase 3
0.7059 Intermediate Similarity NPD1809 Phase 2
0.705 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7015 Intermediate Similarity NPD422 Phase 1
0.7 Intermediate Similarity NPD7286 Phase 2
0.7 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.6967 Remote Similarity NPD1242 Phase 1
0.6954 Remote Similarity NPD3226 Approved
0.6943 Remote Similarity NPD1247 Approved
0.6939 Remote Similarity NPD2309 Approved
0.6929 Remote Similarity NPD2313 Discontinued
0.6929 Remote Similarity NPD3268 Approved
0.6918 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6918 Remote Similarity NPD6166 Phase 2
0.6918 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6914 Remote Similarity NPD5953 Discontinued
0.6913 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6891 Remote Similarity NPD845 Approved
0.6884 Remote Similarity NPD2798 Approved
0.6879 Remote Similarity NPD520 Approved
0.6875 Remote Similarity NPD3748 Approved
0.6852 Remote Similarity NPD1729 Discontinued
0.6839 Remote Similarity NPD3817 Phase 2
0.6829 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6828 Remote Similarity NPD6100 Approved
0.6828 Remote Similarity NPD6099 Approved
0.6815 Remote Similarity NPD919 Approved
0.6809 Remote Similarity NPD411 Approved
0.6809 Remote Similarity NPD3764 Approved
0.6792 Remote Similarity NPD5710 Approved
0.6792 Remote Similarity NPD5711 Approved
0.679 Remote Similarity NPD6020 Phase 2
0.6783 Remote Similarity NPD447 Suspended
0.6779 Remote Similarity NPD3300 Phase 2
0.6777 Remote Similarity NPD2860 Approved
0.6777 Remote Similarity NPD2859 Approved
0.6772 Remote Similarity NPD5494 Approved
0.6765 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6759 Remote Similarity NPD3299 Clinical (unspecified phase)
0.6757 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6748 Remote Similarity NPD7074 Phase 3
0.6742 Remote Similarity NPD256 Approved
0.6742 Remote Similarity NPD255 Approved
0.6741 Remote Similarity NPD2932 Approved
0.6741 Remote Similarity NPD3019 Approved
0.6728 Remote Similarity NPD3818 Discontinued
0.6719 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6716 Remote Similarity NPD1759 Phase 1
0.6715 Remote Similarity NPD3972 Approved
0.6711 Remote Similarity NPD5403 Approved
0.6694 Remote Similarity NPD2934 Approved
0.6694 Remote Similarity NPD1432 Clinical (unspecified phase)
0.6694 Remote Similarity NPD2933 Approved
0.6691 Remote Similarity NPD3266 Approved
0.6691 Remote Similarity NPD3267 Approved
0.669 Remote Similarity NPD1296 Phase 2
0.6689 Remote Similarity NPD5401 Approved
0.6688 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6687 Remote Similarity NPD7054 Approved
0.6667 Remote Similarity NPD6832 Phase 2
0.6667 Remote Similarity NPD1237 Approved
0.6667 Remote Similarity NPD2346 Discontinued
0.6667 Remote Similarity NPD1471 Phase 3
0.6667 Remote Similarity NPD6559 Discontinued
0.6667 Remote Similarity NPD1465 Phase 2
0.6646 Remote Similarity NPD7472 Approved
0.6643 Remote Similarity NPD1019 Discontinued
0.6642 Remote Similarity NPD1758 Phase 1
0.6639 Remote Similarity NPD844 Approved
0.6638 Remote Similarity NPD111 Approved
0.6613 Remote Similarity NPD3020 Approved
0.6606 Remote Similarity NPD6797 Phase 2
0.6605 Remote Similarity NPD2403 Approved
0.6596 Remote Similarity NPD9494 Approved
0.6593 Remote Similarity NPD1548 Phase 1
0.6591 Remote Similarity NPD1241 Discontinued
0.6585 Remote Similarity NPD288 Approved
0.6573 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6571 Remote Similarity NPD2797 Approved
0.6566 Remote Similarity NPD7251 Discontinued
0.6565 Remote Similarity NPD6124 Clinical (unspecified phase)
0.656 Remote Similarity NPD289 Clinical (unspecified phase)
0.6547 Remote Similarity NPD1755 Approved
0.6533 Remote Similarity NPD3400 Discontinued
0.6533 Remote Similarity NPD4628 Phase 3
0.6531 Remote Similarity NPD4308 Phase 3
0.6527 Remote Similarity NPD7808 Phase 3
0.6522 Remote Similarity NPD1610 Phase 2
0.6519 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6516 Remote Similarity NPD7458 Discontinued
0.65 Remote Similarity NPD3225 Approved
0.65 Remote Similarity NPD9258 Approved
0.65 Remote Similarity NPD9256 Approved
0.6494 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6485 Remote Similarity NPD5844 Phase 1
0.6475 Remote Similarity NPD1608 Approved
0.6467 Remote Similarity NPD6104 Discontinued
0.6466 Remote Similarity NPD7159 Clinical (unspecified phase)
0.6457 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6457 Remote Similarity NPD1929 Approved
0.6457 Remote Similarity NPD1930 Approved
0.6444 Remote Similarity NPD9568 Approved
0.6442 Remote Similarity NPD3926 Phase 2
0.6441 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6438 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6438 Remote Similarity NPD5124 Phase 1
0.6437 Remote Similarity NPD4363 Phase 3
0.6437 Remote Similarity NPD4360 Phase 2
0.6435 Remote Similarity NPD9093 Approved
0.6434 Remote Similarity NPD4908 Phase 1
0.6429 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6424 Remote Similarity NPD1196 Approved
0.6424 Remote Similarity NPD7003 Approved
0.6419 Remote Similarity NPD7033 Discontinued
0.6415 Remote Similarity NPD2296 Approved
0.6415 Remote Similarity NPD5402 Approved
0.6405 Remote Similarity NPD1543 Discontinued
0.64 Remote Similarity NPD4362 Clinical (unspecified phase)
0.64 Remote Similarity NPD4361 Phase 2
0.6383 Remote Similarity NPD1283 Approved
0.6383 Remote Similarity NPD1876 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data